PROVIDER PROFILE · NPI 1174286470

Rejani Kannampallil

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

242

Beneficiaries

—

Total drug cost

$325K

Distinct drugs

Brand share

16.1%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

27.5

Cost

68.4

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital

CROSS-REFERENCE